MedPath
HSA Approval

CARVEPEN tablet 25 mg

SIN13590P

CARVEPEN tablet 25 mg

CARVEPEN tablet 25 mg

January 7, 2009

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Therapeutic

Prescription Only

Formulation Information

TABLET

ORAL

Medical Information

C07AG02

carvedilol

Manufacturer Information

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

ELPEN Pharmaceutical Co. Inc

Active Ingredients

Carvedilol

25 mg

Carvedilol
© Copyright 2025. All Rights Reserved by MedPath
CARVEPEN tablet 25 mg - HSA Approval | MedPath